Alberto Margonato Selected Research

Trimetazidine (Vastarel)

7/2014	[Metabolic therapy for heart failure].
3/2013	Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.
9/2011	Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
3/2010	Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
1/2009	Effects of metabolic approach in diabetic patients with coronary artery disease.
9/2006	A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
6/2006	The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition.
4/2006	Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
1/2006	Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
3/2004	[Heart disease and diabetes: from pathophysiology to therapeutic options].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Margonato Research Topics

Disease

27	Heart Failure 01/2022 - 03/2004
13	Myocardial Infarction 12/2021 - 10/2003
13	Coronary Artery Disease (Coronary Atherosclerosis) 12/2018 - 02/2002
11	Thrombosis (Thrombus) 12/2021 - 02/2002
8	Atrial Fibrillation 01/2022 - 01/2015
8	Hemorrhage 06/2021 - 01/2012
7	Hypertension (High Blood Pressure) 06/2021 - 04/2004
6	Left Ventricular Dysfunction 10/2020 - 07/2004
6	Coronary Disease (Coronary Heart Disease) 08/2017 - 10/2003
6	Insulin Resistance 10/2014 - 10/2003
5	Systolic Heart Failure 02/2022 - 09/2011
5	Diabetes Mellitus 06/2021 - 10/2014
4	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 06/2009
4	Death (Near-Death Experience) 01/2022 - 10/2017
4	Cardiomyopathies (Cardiomyopathy) 12/2021 - 03/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2003
4	Acute Coronary Syndrome 07/2014 - 02/2002
3	Stroke (Strokes) 06/2021 - 01/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 06/2006
2	Chest Pain (Chest Pains) 01/2022 - 01/2016
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2021 - 01/2019
2	COVID-19 12/2021 - 01/2021
2	Fibrosis (Cirrhosis) 02/2021 - 01/2019
2	Chronic Renal Insufficiency 11/2019 - 10/2017
2	Cardiogenic Shock 02/2019 - 01/2012
2	Pericarditis 01/2019 - 01/2012
2	Endocarditis 01/2018 - 01/2015
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 05/2014
2	Stable Angina 08/2017 - 03/2015
2	Cardiotoxicity 01/2017 - 09/2009
2	Dyslipidemias (Dyslipidemia) 06/2016 - 01/2013
2	Osteoporosis 06/2016 - 01/2013
2	Angina Pectoris 01/2016 - 01/2003
2	Glucose Intolerance 10/2014 - 10/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2014 - 10/2004
2	Inflammation (Inflammations) 01/2013 - 07/2008
2	Pathologic Constriction (Stenosis) 09/2011 - 07/2004
2	Ischemia 03/2011 - 01/2009
2	Hyperinsulinism (Hyperinsulinemia) 06/2006 - 10/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2006 - 10/2004
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2004 - 07/2004
2	Microvascular Angina (Cardiac Syndrome X) 04/2004 - 01/2003
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Infections 01/2021

Drug/Important Bio-Agent (IBA)

11	Trimetazidine (Vastarel)IBA 07/2014 - 02/2002
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2004
6	AnticoagulantsIBA 06/2021 - 01/2015
6	Nonesterified Fatty Acids (NEFA)IBA 01/2009 - 02/2002
5	Fatty Acids (Saturated Fatty Acids)IBA 07/2014 - 06/2006
4	PolymersIBA 01/2020 - 07/2016
4	CarbohydratesIBA 07/2014 - 06/2006
4	Carvedilol (Coreg)FDA LinkGeneric 08/2013 - 12/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004 - 02/2002
3	CreatinineIBA 01/2022 - 10/2020
3	Sirolimus (Rapamycin)FDA Link 01/2020 - 06/2012
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019 - 01/2014
3	Pharmaceutical PreparationsIBA 01/2015 - 12/2004
3	Adenosine Triphosphate (ATP)IBA 08/2013 - 04/2006
3	Endothelin-1 (Endothelin 1)IBA 01/2006 - 02/2002
2	Chromogranin AIBA 02/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
2	CytokinesIBA 01/2021 - 07/2008
2	Dabigatran FDA Link 10/2020 - 11/2019
2	RivaroxabanIBA 10/2020 - 11/2019
2	apixabanIBA 10/2020 - 11/2019
2	Vitamin K FDA Link 04/2020 - 01/2015
2	BESIBA 01/2019 - 10/2017
2	IvabradineIBA 07/2018 - 02/2017
2	C-Reactive ProteinIBA 01/2018 - 12/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2017 - 01/2013
2	Mineralocorticoid Receptor AntagonistsIBA 02/2017 - 06/2016
2	Metformin (Glucophage)FDA LinkGeneric 06/2016 - 01/2013
2	Sertraline (Zoloft)FDA LinkGeneric 06/2016 - 01/2013
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2016 - 01/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 06/2016 - 01/2013
2	Simvastatin (Zocor)FDA LinkGeneric 06/2016 - 01/2013
2	Propafenone (Rythmol)FDA LinkGeneric 06/2016 - 01/2013
2	Ketone BodiesIBA 07/2014 - 01/2008
2	Phosphocreatine (Neoton)IBA 08/2013 - 04/2006
2	Antihypertensive Agents (Antihypertensives)IBA 02/2012 - 08/2009
2	Therapeutic UsesIBA 01/2009 - 01/2008
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 07/2008 - 01/2003
2	Arginine (L-Arginine)FDA Link 04/2004 - 01/2003
1	vasostatin IIBA 02/2022
1	TroponinIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021
1	SodiumIBA 01/2021
1	SymportersIBA 01/2021

Therapy/Procedure

31	Therapeutics 01/2022 - 02/2002
15	Percutaneous Coronary Intervention 01/2021 - 06/2012
10	Stents 12/2021 - 10/2003
4	Drug-Eluting Stents 07/2016 - 06/2012
3	Drug Therapy (Chemotherapy) 08/2017 - 12/2015
2	Defibrillators (Defibrillator) 12/2021 - 01/2013
2	Heart Transplantation (Grafting, Heart) 12/2020 - 01/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2015 - 09/2011
1	Patient Readmission 01/2022
1	CT protocol 01/2022